22. Robinson C, Shore R C, Brookes S J, Strafford S, Wood S R, Kirkham J. The chemistry of enamel caries. Crit Rev Oral Biol Med 2000; 11 (4): 481-495.
Top
Tables
Age group Range Number Percentage
1 12-21 40 44.4
2 22-31 39 43.3
3 32-41 8 8.9
4 >41 3 3.3
Total 90 100%
Table 1: Distribution of subjects enrolled in the main study according to age.
Gender Numbers Percentage
Male 35 38.9
Female 55 61.1
Total 90 100%
Table 2: Distribution of subjects enrolled in the study according to gender.
Score Description
0 No or slight change in enamel translucency after prolonged air drying (>5s)
1
1a Opacity (white) hardly visible on the wet surface, but distinctly visible after air-drying (>5s).
Opacity (brown) hardly visible on the wet surface, but distinctly visible after air-drying (>5s)
2
2a Opacity (white) distinctly visible with out air-drying.
Opacity (brown) distinctly visible with out air-drying.
3 Localised enamel breakdown in opaque or discoloured enamel and or greyish discolouration from the underlying dentine.
4 Cavitation in opaque or discoloured enamel exposing the dentine beneath.
Table 3: Clinical severity index scores 12.
Score D value Description
0 <10 Sound
1 10-14 Enamel caries in the outer half
2 15-20 Caries in enamel up to DEJ
3 21-30 Caries in enamel reaching DEJ with some dentine demineralisation
4 ?31 Deep dentinal caries.
Table 4: Recommended DIAGNOdent cut-off points as stated by the manufacturer.
ECM Score Corresponding ECM end value Possible clinical inferences
0 > 10.00 MO Sound enamel
1 10.00 to 2.50MO Lesions up to DEJ
2 2.5 to 0.151 MO Lesions in dentine
3 Equal or less than 0.150 MO Deep dentinal lesions
Table 5: ECM scores, corresponding end values and possible clinical inferences (ECM Manual, 2000).
Active ingredients in the reductant were as follows: % wt/wt
Water To make up 100%
Sodium Benzoate NF 0.50000
Sodium tripolyphosphate 3.00000
Sodium fluoride 1100 ppm F
Xylitol 1.00000
Zinc Chloride 0.75000
Sodium Citrate USP 2.60000
Methyl paraben 0.12000
Sodium Methyl Cocoyl Taurate 0.60000
Riboflavin 0.00010
Flavour (Noville AN114153) 1.00000
Table 6: Active ingredients of the remineralising solution used after Ozone treatment.
Outcome measurement Range included in the study Relation with carious activity
Clinical severity score 1-3 Parallel
DIAGNOdent reading 10-99 Parallel
DIAGNOdent score 1-4 Parallel
ECM reading 0.05-5000 MW Inverse
ECM score 0-3 Parallel
Table 7: Relationship of measurements taken by three diagnostic tools to quantify carious activity in POPFC lesions.
Location Tooth number Total
1st premolars 2nd premolars 1st molars 2nd molars 3rd molars
Mesial 12 7 1 11 2 33
Central 6 19 36 56 14 131
Distal 25 16 26 27 0 94
Total 43 42 63 94 16 258
Table 8: Distribution of POPFC lesions within the treatment and control groups according to lesion location.
Paired comparisons Weighed Kappa value
Fissures Pits
Severity set 1&2 0.685* 0.645*
Severity set 1&3 0.639* 0.671*
Severity set 1&4 0.635* 0.610*
Severity set 2&3 0.614* 0.570*
Severity set 2&4 0.610* 0.600*
Severity set 3&4 0.650* 0.640*
Mean 0.639* 0.622*
Table 9: Weighed Kappa values for the ECM scores in the four sets of readings taken for the teeth within one visit (*p<0.001).
Clinical severity scores Treatment group Control group
Number % Number %
1 63 49.6 79 62.2
2 53 41.7 39 30.7
3 11 8.7 9 7.1
Total 127 100.0 127 100.0
DIAGNOdent scores DIAGNOdent ranges Treatment group Control group
Number % Number %
1 10-14 8 6.4 13 10.3
2 15-20 20 16.0 24 18.8
3 21-30 36 28.8 34 26.6
4 ?31 61 48.8 57 44.5
ECM score
Corresponding end values MO Treatment group Control group
Number % Number %
0 > 10.00 36 28.1 45 35.2
1 10.00 to 2.50 39 30.5 37 28.9
2 2.5 to 0.151 47 36.7 42 32.8
3 = 0.150 6 4.7 4 3.1
Table10: Distribution of POPFC lesions within the treatment and control groups (p values between groups are 0.055, 0.240, 0.130 for the clinical severity, DIAGNOdent and ECM scores respectively).
DIAGNOdent score Clinical severity score
Scores Total Pits Fissures Total Pits Fissures
ECM score 0.20** 0.25** 0.17** 0.31** 0.28** 0.33**
DIAGNOdent score 1.00 1.00 1.00 0.24** 0.18* 0.28**
* (p<0.05)
** (p<0.01)
Table 11: Spearmen’s correlation values between scores obtained from the diagnostic tools at baseline.
Clinical severity scores DIAGNOdent scores ECM scores
Score change Treatment
Number % Control
Number % Treatment
Number % Control
Number % Treatment
Number % Control
Number %
-3 - - - - 0 0.0 0 0.0 0 0.0 0 0.0
-2 1 0.9 0 0.0 2 1.6 5 4.2 5 4.2 0 0.0
-1 12 10.5 6 5.3 14 10.9 16 13.4 24 20.0 17 14.2
0 85 74.6 93 81.6 71 61.7 63 52.9 71 59.2 71 59.2
1 16 14.0 15 13.3 23 20.0 27 22.7 17 14.2 23 19.2
2 0 0.0 0 0.0 3 2.6 7 5.9 3 2.5 9 7.5
3 - - - - 2 1.7 1 0.8 0 0.0 0 0.0
P =* 0.724 0.050 0.060 0.086 0.210 0.005
P=** 0.315 0.978 0.001
-not possible. Only a 2 score difference is present.
*from baseline
**between groups
Table 12: The number and percentage of teeth experiencing a change in the diagnostic scores after one month, in the treatment and the control groups.
Group p value Mean Lesion no. SD SE
Loge DIAGNOdent change
Treatment 0.016* 0.0783 116 0.34 0.03
Control 0.016* 0.0865 119 0.39 0.04
Change 0.701** -0.001 115 0.46 0.04
Loge ECM change
Treatment 0.278* 0.116 120 1.37 0.13
Control 0.029* -0.255 120 1.37 0.12
Change 0.019** 0.410 120 1.51 0.14
Loge ECM change after excluding baseline ECM score 0 (62 pairs)
Treatment 0.008* 0.391 120 1.34 0.14
Control 0.491* 0.096 120 1.22 0.14
Change 0.021** 0.451 62 1.50 0.19
Loge ECM change for lesions with baseline ECM score 0 (17 pairs)
Treatment 0.013* -0.5630 32 1.22 0.21
Control 0.000* -0.960 42 1.34 0.21
Change 0.645** 0.1491 17 1.31 0.32
*from baseline
**between groups after adjusting for block effect
Table 13: Change in ECM readings after one month.
Figures
Figure 1: Mean (± SE) ECM change after 1 month in the Ozone treatment and control groups categorised by the tooth sequence from midline.
Figure 2: Mean (± SE) ECM change after 1 month in the Ozone treatment and control groups categorised by baseline ECM scores.
Legends
• Table 1: Distribution of subjects enrolled in the main study according to age.
• Table 2: Distribution of subjects enrolled in the study according to gender.
• Table 3: Clinical severity index scores 12.
• Table 4: Recommended DIAGNOdent cut-off points as stated by the manufacturer.
• Table 5: ECM scores, corresponding end values and possible clinical inferences (ECM Manual, 2000).
• Table 6: Active ingredients of the remineralising solution used after Ozone treatment.
• Table 7: Relationship of measurements taken by three diagnostic tools to quantify carious activity in POPFC lesions.
• Table 8: Distribution of POPFC lesions within the treatment and control groups according to lesion location.
• Table 9: Weighed Kappa values for the ECM scores in the four sets of readings taken for the teeth within one visit (*p<0.001).
• Table10: Distribution of POPFC lesions within the treatment and control groups (p values between groups are 0.055, 0.240, 0.130 for the clinical severity, DIAGNOdent and ECM scores respectively). Table 11: Spearmen’s correlation values between scores obtained from the diagnostic tools at baseline.
• Table 12: The number and percentage of teeth experiencing a change in the diagnostic scores after one month, in the treatment and the control groups.
• Table 13: Change in ECM readings after one month.
• Figure 1: Mean (± SE) ECM change after 1 month in the Ozone treatment and control groups categorised by the tooth sequence from midline.
• Figure 2: Mean (± SE) ECM changes after 1 month in the Ozone treatment and control groups categorised by baseline ECM scores.
Acknowledgement
Authors would like to thank Dr. Mike Stevenson for his expert statistical advice. Also we would like to thank all the participants who gave from their time and effort to make this study possible.
Source of fund:
The PhD was an award from Jordan University of Science and Technology, Irbid Jordan.